At a cellular level in rats, AVP has been shown to induce changes that could lead to CKD, including mesangial cell proliferation and TGF-beta-associated collagen production, which can be inhibited by V1AR antagonists (V1ARA) [71, 72]. Here, AVP is linked to chronic kidney disease.